| Katrina Regula, MD | |
|
701 White Pond Dr Ste 100, Akron, OH 44320-1193 | |
| (330) 865-1252 | |
| (330) 865-1260 |
| Full Name | Katrina Regula |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 701 White Pond Dr Ste 100, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003063561 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 35.09296 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katrina Regula, MD 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 865-1252 | Katrina Regula, MD 701 White Pond Dr Ste 100, Akron, OH 44320-1193 Ph: (330) 865-1252 |
News Archive
"Menstrual hygiene issues should be integrated into programs and policies across sectors, including water, sanitation and hygiene, reproductive health, emergency management, and education, notes a new report" by WaterAid, IRIN reports.
In a letter released today by the White House today to Sen. Edward Kennedy, chairman of the Senate Committee on Health, Education, Labor and Pensions, and Sen. Max Baucus, chairman of the Senate Finance Committee, President Obama "suggests he may be open to a requirement that every American have health insurance, even though he opposed the so-called individual mandate in the presidential campaign," the Washington Post reports.
The nation's largest health insurance company, United Healthcare, launched a new push this week to get employees to directly lobby U.S. Senators for weaker health reform and higher insurer profits. The new campaign, in an e-mail sent to all employees Nov. 10, offers employees template letters to send from company computers on company time and urges them to write grassroots-style letters to the editor to local newspapers. Consumer Watchdog, which obtained the letters, called on the Senate and newspapers to reject this deceptive corporate-directed campaign.
Oncolytics Biotech Inc. today announced preliminary results from a U.S. Phase 2 clinical trial (REO 017) using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar®) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio (CTRC).
› Verified 2 days ago
Dr. Hiba Khankan, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8178 Fax: 330-543-8157 | |
Amanda Gogol-tagliaferro, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 215 W Bowery St, Akron, OH 44308 Phone: 330-543-8530 Fax: 330-543-3731 | |
Laura Discenna, Pediatrics Medicare: Medicare Enrolled Practice Location: 1463 Canton Rd, Akron, OH 44312 Phone: 330-253-4931 Fax: 330-253-8619 | |
Michael L. Bowman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8004 | |
Sarah E Kline Krammes, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000 | |
Vanisha Patel, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Third Floor, Akron, OH 44308 Phone: 330-543-5191 |